FTC antitrust war wages on
The US Federal Trade Commission's campaign against reverse payments between innovator pharmaceutical companies and generics stepped up a gear last month
Eileen McDermott, New York
In its latest bid to curb these payments , the FTC filed a complaint against Solvay Pharmaceuticals and three generic drug makers.
The complaint alleges that Watson Pharmaceuticals, Par Pharmaceuticals and Paddock Laboratories agreed to abandon their...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.